Breaking Research Published in AACC’s Clinical Chemistry Journal Could Reduce Recurrence of Heart Attacks, Death in Patients with Cardiovascular Disease
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))Research published today in AACC’s Clinical Chemistry journal shows that a test can identify patients with a history of cardiovascular disease who are at high risk of another heart attack or death and would benefit from treatment with the drug vorapaxar. This study and two others on tests that predict risk of adverse cardiovascular events are featured in the Cardiovascular Disease issue of Clinical Chemistry.